Improving Outcomes for Multidrug-Resistant Tuberculosis: Aggressive Regimens Prevent Treatment Failure and Death

Background. Evidence is sparse regarding the optimal construction of regimens to treat multidrug-resistant (MDR) tuberculosis disease due to strains of Mycobacterium tuberculosis resistant to at least both isoniazid and rifampin. Given the low potency of many second-line antituberculous drugs, we hy...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Infect Dis
Päätekijät: Velásquez, Gustavo E., Becerra, Mercedes C., Gelmanova, Irina Y., Pasechnikov, Alexander D., Yedilbayev, Askar, Shin, Sonya S., Andreev, Yevgeny G., Yanova, Galina, Atwood, Sidney S., Mitnick, Carole D., Franke, Molly F., Rich, Michael L., Keshavjee, Salmaan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2014
Aiheet:
Articles and Commentaries
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4305127/
https://ncbi.nlm.nih.gov/pubmed/24729493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciu209
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia